OBJECTIVETo assess the change in level of diabetes quality management in primary care groups and outpatient clinics after feedback and tailored support.
RESEARCH DESIGN AND METHODSThis before-and-after study with a 1-year follow-up surveyed quality managers on six domains of quality management. Questionnaires measured organization of care, multidisciplinary teamwork, patient centeredness, performance results, quality improvement policy, and management strategies (score range 0-100%). Based on the scores, responders received feedback and a benchmark and were granted access to a toolbox of quality improvement instruments. If requested, additional support in improving quality management was available, consisting of an elucidating phone call or a visit from an experienced consultant. After 1 year, the level of quality management was measured again.
RESULTSOf the initially 60 participating care groups, 51 completed the study. The total quality management score improved from 59.8% (95% CI 57.0-62.6%) to 65.1% (62.8-67.5%; P < 0.0001). The same applied to all six domains. The feedback and benchmark improved the total quality management score (P = 0.001). Of the 44 participating outpatient clinics, 28 completed the study. Their total score changed from 65.7% (CI 60.3-71.1%) to 67.3% (CI 62.9-71.7%; P = 0.30). Only the results in the domain multidisciplinary teamwork improved (P = 0.001).
CONCLUSIONSMeasuring quality management and providing feedback and a benchmark improves the level of quality management in care groups but not in outpatient clinics. The questionnaires might also be a useful asset for other diabetes care groups, such as Accountable Care Organizations.To improve diabetes care, it might be important to focus on quality management (QM), especially because more health-care providers are involved and organizations are becoming more complex (1). QM comprises procedures to monitor, assess, and enhance the quality of care (2). Most studies on quality improvement strategies focus on performance indicators such as the number of patients having their HbA 1c measured (3-5). A study in eight European countries showed high levels on process indicators and lower levels on intermediate outcome indicators (6). Care providers